Correlation Between Pharmaceuticals Ultrasector and Ultrashort Emerging
Can any of the company-specific risk be diversified away by investing in both Pharmaceuticals Ultrasector and Ultrashort Emerging at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharmaceuticals Ultrasector and Ultrashort Emerging into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pharmaceuticals Ultrasector Profund and Ultrashort Emerging Markets, you can compare the effects of market volatilities on Pharmaceuticals Ultrasector and Ultrashort Emerging and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharmaceuticals Ultrasector with a short position of Ultrashort Emerging. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharmaceuticals Ultrasector and Ultrashort Emerging.
Diversification Opportunities for Pharmaceuticals Ultrasector and Ultrashort Emerging
-0.66 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Pharmaceuticals and Ultrashort is -0.66. Overlapping area represents the amount of risk that can be diversified away by holding Pharmaceuticals Ultrasector Pr and Ultrashort Emerging Markets in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ultrashort Emerging and Pharmaceuticals Ultrasector is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharmaceuticals Ultrasector Profund are associated (or correlated) with Ultrashort Emerging. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ultrashort Emerging has no effect on the direction of Pharmaceuticals Ultrasector i.e., Pharmaceuticals Ultrasector and Ultrashort Emerging go up and down completely randomly.
Pair Corralation between Pharmaceuticals Ultrasector and Ultrashort Emerging
Assuming the 90 days horizon Pharmaceuticals Ultrasector Profund is expected to generate 0.68 times more return on investment than Ultrashort Emerging. However, Pharmaceuticals Ultrasector Profund is 1.47 times less risky than Ultrashort Emerging. It trades about 0.0 of its potential returns per unit of risk. Ultrashort Emerging Markets is currently generating about -0.03 per unit of risk. If you would invest 2,062 in Pharmaceuticals Ultrasector Profund on April 8, 2025 and sell it today you would lose (193.00) from holding Pharmaceuticals Ultrasector Profund or give up 9.36% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pharmaceuticals Ultrasector Pr vs. Ultrashort Emerging Markets
Performance |
| Timeline |
| Pharmaceuticals Ultrasector |
| Ultrashort Emerging |
Pharmaceuticals Ultrasector and Ultrashort Emerging Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pharmaceuticals Ultrasector and Ultrashort Emerging
The main advantage of trading using opposite Pharmaceuticals Ultrasector and Ultrashort Emerging positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharmaceuticals Ultrasector position performs unexpectedly, Ultrashort Emerging can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ultrashort Emerging will offset losses from the drop in Ultrashort Emerging's long position.The idea behind Pharmaceuticals Ultrasector Profund and Ultrashort Emerging Markets pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |